
British Society for Antimicrobial Chemotherapy
BSAC on MedicMessJournal of Antimicrobial Chemotherapy
Indexed in MEDLINE (PubMed). Published by Oxford University Press for the British Society for Antimicrobial Chemotherapy.
Publishing in Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy is published for the British Society for Antimicrobial Chemotherapy by Oxford University Press. It covers the clinical and laboratory study of antimicrobials, including treatment, prescribing, stewardship and resistance. The journal mainly publishes human medicine research and considers veterinary work with global health relevance. Original articles and brief reports sit alongside systematic and narrative reviews, correspondence, case reports, viewpoints and debate pieces.
Authors can use the standard subscription route without a charge. Optional open access generally costs £3,132 before tax, with a lower quoted fee for Research Letters and possible institutional or society support. The journal generally excludes compound synthesis, disinfectant activity, drug stability studies and undefined natural extracts. Its 2025 median time from submission to first decision was 15 days. Referees are anonymous to authors, and viewpoints and correspondence are not routinely sent for external review. Unsolicited reviews and debate pieces require contact with the Editor-in-Chief before submission.
Free subscriber access
Free with a subscription: the author guide in one place
Word limits, abstract lengths and fees for each article type, and a checklist before you submit. Enter your email to unlock this journal and every other guide.
You'll also receive The Weekend Round every Saturday.- Original articles
Full reports of new antimicrobial research, including clinical and laboratory studies.
- Words
- 3,500
- Abstract
- 250
- Figures & tables
- —
- References
- —
- Brief reports
Short original research reports in the same format as Original articles.
- Words
- 1,500
- Abstract
- 250
- Figures & tables
- 2
- References
- 20
- Correspondence
Letters on antimicrobial topics, particularly in response to work published in the journal.
- Words
- 800
- Abstract
- —
- Figures & tables
- 1
- References
- 10
- Case reports
Important clinical cases submitted as Correspondence, with patient anonymity preserved.
- Words
- 800
- Abstract
- —
- Figures & tables
- 1
- References
- 10
- Systematic review articles
Systematic evidence synthesis with a structured synopsis and applicable PRISMA reporting materials.
- Words
- —
- Abstract
- —
- Figures & tables
- —
- References
- —
- Review articles
Broad topical reviews; contact the Editor-in-Chief before preparing an unsolicited review.
- Words
- —
- Abstract
- 250
- Figures & tables
- —
- References
- —
- Viewpoint
Topical opinion pieces, usually around 800 to 1,000 words; discuss the idea before writing.
- Words
- —
- Abstract
- 150
- Figures & tables
- —
- References
- —
- For debate
Arguments on contentious antimicrobial topics; secure the Editor-in-Chief's agreement before submission.
- Words
- 2,500
- Abstract
- 150
- Figures & tables
- —
- References
- —
The standard subscription route has no charge. Optional open access usually costs £3,132 before tax; the fee calculator quotes £1,566 for Research Letters. Institutional agreements and society membership may reduce the charge. The guide says Viewpoints become freely available immediately without a charge, although the optional licence calculator quotes a fee.
Before you submit
- Use continuous line numbers and include Funding and Transparency declarations sections where required.
- Register clinical trials and give the registry and number in the abstract and main text.
- Provide CONSORT materials for randomised trials and PRISMA materials for systematic reviews of trials.
- Declare previous publication or a rejected JAC submission in the covering letter.
- Disclose any large language model use in the cover letter and manuscript.
- Return a requested revision within six weeks or the journal may treat it as a new submission.
Present it first.
Similar journals.
Frequently asked
- Is Journal of Antimicrobial Chemotherapy indexed in PubMed?
- Yes. Journal of Antimicrobial Chemotherapy is indexed in MEDLINE, so its articles are in PubMed with a PMID.
- How much does it cost to publish in Journal of Antimicrobial Chemotherapy?
- There is a free route: authors can publish without a fee. Open access costs £3,132.
- Does Journal of Antimicrobial Chemotherapy accept case reports?
- Yes. Journal of Antimicrobial Chemotherapy publishes case reports.
- What is the Impact Factor of Journal of Antimicrobial Chemotherapy?
- Journal of Antimicrobial Chemotherapy states an Impact Factor of 4.1 for 2025.
- How long does Journal of Antimicrobial Chemotherapy take to decide?
- About 15 days from submission to first decision.
- What kind of peer review does Journal of Antimicrobial Chemotherapy use?
- Single-blind peer review.
MEDLINE · Free route · First decision in 15 days
- Accepted work
- Original research · Case report · Systematic review · Literature review
- Acceptance rate
- Not stated
- Peer review
- Single-blind
- Access
- Subscription, with optional open access articles · Subscribe ↗
Checked against the journal’s author guide · updated 14 Oct 2026



